ANAB three-lens brief
Evidence-based stock research on ANAB. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Performance
50-day MA below 200-day MA (death-cross regime); price below both. · Debt-to-equity of 2547% — balance-sheet-heavy.
- 50-day MA below 200-day MA (death-cross regime); price below both.
- Analyst mean target $87.25 — 79% above current (8 analysts).
- Debt-to-equity of 2547% — balance-sheet-heavy.
- Reported earnings on 2026-11-10.
ANAB closed at $48.77 (+0.81%) as of 2026-11-12. Market cap: $1.46B. Price is below the 50-day MA and below the 200-day MA. Positives: analyst mean target $87.25 — 79% above current (8 analysts).. Concerns: 50-day MA below 200-day MA (death-cross regime); price below both.; debt-to-equity of 2547% — balance-sheet-heavy.. Last quarter: Revenue $27.49M, net income $177.32M.
Why three lenses on ANAB, not one.
A single reasoning model has blind spots it doesn’t know about. We examine ANAB across Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://www.clearpathinvest.app/embed/ANAB" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath ANAB brief"></iframe>